Rocket Pharmaceuticals In...

5.56
-0.74 (-11.75%)
At close: Apr 03, 2025, 3:59 PM
5.59
0.54%
After-hours: Apr 03, 2025, 06:10 PM EDT

Rocket Pharmaceuticals Statistics

Share Statistics

Rocket Pharmaceuticals has 106.63M shares outstanding. The number of shares has increased by 17.46% in one year.

Shares Outstanding 106.63M
Shares Change (YoY) 17.46%
Shares Change (QoQ) 0.28%
Owned by Institutions (%) 99.99%
Shares Floating 98.97M
Failed to Deliver (FTD) Shares 27.26K
FTD / Avg. Volume 1.63%

Short Selling Information

The latest short interest is 11.7M, so 11% of the outstanding shares have been sold short.

Short Interest 11.7M
Short % of Shares Out 11%
Short % of Float 11.91%
Short Ratio (days to cover) 6.8

Valuation Ratios

The PE ratio is -4.61 and the forward PE ratio is -4.51. Rocket Pharmaceuticals's PEG ratio is 0.71.

PE Ratio -4.61
Forward PE -4.51
PS Ratio 0
Forward PS 0.9
PB Ratio 2.57
P/FCF Ratio -5.68
PEG Ratio 0.71
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Rocket Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.3, with a Debt / Equity ratio of 0.06.

Current Ratio 9.3
Quick Ratio 9.3
Debt / Equity 0.06
Debt / EBITDA -0.09
Debt / FCF -0.12
Interest Coverage 144.86

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-865.37K
Employee Count 299
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -75.3% in the last 52 weeks. The beta is 1.02, so Rocket Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.02
52-Week Price Change -75.3%
50-Day Moving Average 9.38
200-Day Moving Average 15.49
Relative Strength Index (RSI) 29.99
Average Volume (20 Days) 1.67M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -273.2M
Net Income -258.75M
EBITDA -273.2M
EBIT -260.63M
Earnings Per Share (EPS) -2.73
Full Income Statement

Balance Sheet

The company has 163.63M in cash and 25.5M in debt, giving a net cash position of 138.14M.

Cash & Cash Equivalents 163.63M
Total Debt 25.5M
Net Cash 138.14M
Retained Earnings -1.22B
Total Assets 527.7M
Working Capital 337.5M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -209.72M and capital expenditures 0, giving a free cash flow of -209.72M.

Operating Cash Flow -209.72M
Capital Expenditures 0
Free Cash Flow -209.72M
FCF Per Share -2.21
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for RCKT is $47, which is 648.4% higher than the current price. The consensus rating is "Buy".

Price Target $47
Price Target Difference 648.4%
Analyst Consensus Buy
Analyst Count 10
Stock Forecasts

Stock Splits

The last stock split was on Jan 5, 2018. It was a backward split with a ratio of 1:4.

Last Split Date Jan 5, 2018
Split Type backward
Split Ratio 1:4

Scores

Altman Z-Score 2.55
Piotroski F-Score 3